|
|
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3951-3959.
Prepublished online as a Blood First Edition Paper on January 15, 2004; DOI 10.1182/blood-2003-11-3763.

Submitted November 5, 2003
Accepted January 5, 2004
Transplantation tolerance induced by intranasal administration of HY peptides
Jian-Guo Chai, Edward James, Hamlata Dewchand, Elizabeth Simpson, and Diane Scott*
Transplantation Biology Group, MRC Clinical Sciences Centre, Imperial College, London, Hammersmith Campus, London, United Kingdom
* Corresponding author; email: diane.scott{at}csc.mrc.ac.uk.
Induction of antigen specific tolerance to transplantation antigens is desirable to control host-versus-graft and graft-versus-host reactions. Following molecular identification of a set of minor histocompatibility (H) antigens, we have used selected HY peptide epitopes for this purpose. Intranasal administration of individual MHC class II restricted HY peptides induces indefinite survival of syngeneic male skin grafts and allows engraftment of male bone marrow. Tolerance involves linked suppression to additional HY epitopes on test grafts. Long-term tolerance also requires suppression of emerging thymic emigrants. It does not involve deletion: HY peptide specific CD4+ and CD8+ T cells expand on re-exposure to male antigen; these expansions are smaller in tolerant than control mice and fewer HY-specific cells from tolerant females secrete IFN and IL10. Significantly, CD4+ cells from peptide pre-treated females fail to make IL2 responses to cognate peptide, limiting expansion of the HY specific CD8+ populations that can cause graft rejection. Consistent with this, tolerance induction by HY peptide is abrogated by co-administration of LPS. IL10 does not appear to be critically involved, since tolerance is inducible in IL10 deficient mice. Adoptive transfer of tolerance into naive neonatal recipients by splenocytes from long-term tolerant donors provides evidence for involvement of regulatory cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Campbell, K. F. Buckland, S. J. McMillan, J. Kearley, W. L.G. Oldfield, L. J. Stern, H. Gronlund, M. van Hage, C. J. Reynolds, R. J. Boyton, et al.
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression
J. Exp. Med.,
July 6, 2009;
206(7):
1535 - 1547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Baruah, I. E. Dumitriu, T. H. Malik, H. T. Cook, J. Dyson, D. Scott, E. Simpson, and M. Botto
C1q enhances IFN-{gamma} production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells
Blood,
April 9, 2009;
113(15):
3485 - 3493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zang, M. Lin, S. Kalache, N. Zhang, B. Kruger, A. M. Waaga-Gasser, M. Grimm, W. Hancock, P. Heeger, B. Schroppel, et al.
Inhibition of the Alloimmune Response through the Generation of Regulatory T Cells by a MHC Class II-Derived Peptide
J. Immunol.,
December 1, 2008;
181(11):
7499 - 7506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Verginis, K. A. McLaughlin, K. W. Wucherpfennig, H. von Boehmer, and I. Apostolou
Induction of antigen-specific regulatory T cells in wild-type mice: Visualization and targets of suppression
PNAS,
March 4, 2008;
105(9):
3479 - 3484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Chai, D. Coe, D. Chen, E. Simpson, J. Dyson, and D. Scott
In Vitro Expansion Improves In Vivo Regulation by CD4+CD25+ Regulatory T Cells
J. Immunol.,
January 15, 2008;
180(2):
858 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Robertson, J.-G. Chai, M. Millrain, D. Scott, F. Hashim, E. Manktelow, F. Lemonnier, E. Simpson, and J. Dyson
Natural Regulation of Immunity to Minor Histocompatibility Antigens
J. Immunol.,
March 15, 2007;
178(6):
3558 - 3565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Maile, C. M. Barnes, A. I. Nielsen, A. A. Meyer, J. A. Frelinger, and B. A. Cairns
Lymphopenia-Induced Homeostatic Proliferation of CD8+ T Cells Is a Mechanism for Effective Allogeneic Skin Graft Rejection following Burn Injury.
J. Immunol.,
June 1, 2006;
176(11):
6717 - 6726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zang, S. Kalache, M. Lin, B. Schroppel, and B. Murphy
MHC Class II-Mediated Apoptosis by a Nonpolymorphic MHC Class II Peptide Proceeds by Activation of Protein Kinase C
J. Am. Soc. Nephrol.,
December 1, 2005;
16(12):
3661 - 3668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lee
New approaches for preventing and treating chronic graft-versus-host disease
Blood,
June 1, 2005;
105(11):
4200 - 4206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Higuchi, T. Maruyama, A. Jaramillo, and T. Mohanakumar
Induction of Obliterative Airway Disease in Murine Tracheal Allografts by CD8+ CTLs Recognizing a Single Minor Histocompatibility Antigen
J. Immunol.,
February 15, 2005;
174(4):
1871 - 1878.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|